Migraines: Calls for 'life changing' drug Aimovig on NHS in England
The 'life-changing' injection has been approved for use in Scotland, but not yet in England. (Source: BBC News | Health | UK Edition)
Source: BBC News | Health | UK Edition - May 24, 2019 Category: Consumer Health News Source Type: news

Mother who suffered crippling migraines for five years claims she's cured after cutting out EGGS
Tracy Richardson, 55, from Wallingford, Oxfordshire had been plagued by debilitating headaches since 2014 which left her bed-ridden for days and struggling to work. (Source: the Mail online | Health)
Source: the Mail online | Health - May 23, 2019 Category: Consumer Health News Source Type: news

Medical News Today: What causes dizziness?
Some common reasons for feeling dizzy include migraine episodes, low blood pressure, motion sickness, and stress. Resolving the underlying cause will usually improve the symptoms. Learn more here. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - May 23, 2019 Category: Consumer Health News Tags: Ear, Nose and Throat Source Type: news

Mother, 35, reveals how she had half her SKULL removed after suffering a brain aneurysm
Lisa Ross, now 35, of Cumbernauld, Lanarkshire, thought she just had a migraine while bending down to pick up weights during a body-pump class on March 2 2017. (Source: the Mail online | Health)
Source: the Mail online | Health - May 21, 2019 Category: Consumer Health News Source Type: news

Study Finds CBD Effective In Treating Heroin Addiction
(CNN) — Cannabidiol, the non-psychoactive ingredient in hemp and marijuana, could treat opioid addiction, a new study says. Given to patients with heroin addiction, cannabidiol, also known as CBD, reduced their cravings for the illicit drug as well as their levels of anxiety. “The intense craving is what drives the drug use,” said Yasmin Hurd, the lead researcher on the study and director of the Addiction Institute of Mount Sinai. “If we can have the medications that can dampen that [craving], that can greatly reduce the chance of relapse and overdose risk.” CBD: What Is It And Why Do People U...
Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire - May 21, 2019 Category: Consumer Health News Authors: Health – CBS Boston Tags: Health News CBD CNN Source Type: news

Migraine: What happens in the brain when you have one?
It's estimated that one in seven people are affected by migraines. (Source: BBC News | Health | UK Edition)
Source: BBC News | Health | UK Edition - May 20, 2019 Category: Consumer Health News Source Type: news

HEALTH NOTES: Jab offers hope to migraine patients
A revolutionary drug that halts migraines in their tracks is giving Britain's NHS patients their lives back. (Source: the Mail online | Health)
Source: the Mail online | Health - May 18, 2019 Category: Consumer Health News Source Type: news

Woman, 23, claims she 'has had a never-ending headache for eight years'
Ashley Rogers, 23, from Houston, Texas, was a keen volleyball player when in January 2011, she suffered a blow to the head by a softball. (Source: the Mail online | Health)
Source: the Mail online | Health - May 17, 2019 Category: Consumer Health News Source Type: news

Chronic Migraine: Why we Get it Wrong, Why it Matters
Episodic or chronic? Distinguishing between the 2 types of migraine is essential to ensure optimal treatment. Meet Abigail and Martin. Who has which headache?   (Source: ConsultantLive)
Source: ConsultantLive - May 15, 2019 Category: Internal Medicine Authors: Peter McAllister, MD Tags: Headache and Migraine Source Type: news

Omron Ventures joins Theranica ’s Series B funding round as strategic investor
Theranica, an Israel-based biomedical technology company focused on developing advanced electroceuticals for migraine and other prevalent diseases, announced that Omron Ventures has joined its $35M series B funding round, which was announced earlier this March. The investment sum by Omron Ventures has not been disclosed.   (Source: mobihealthnews)
Source: mobihealthnews - May 14, 2019 Category: Information Technology Source Type: news

Substantial Evidence Supports Disability Insurer's Termination Of Benefits
NEW ORLEANS - A disability insurer did not abuse its discretion in terminating a claimant's long-term disability (LTD) benefits because substantial evidence supported the insurer's finding that the claimant was not disabled from her own occupation as an attorney as a result of migraine headaches, the Fifth Circuit U.S. Court of Appeals said April 4 (Amanda C. Foster v. Principal Life Insurance Co., No. 17-30997, 5th Cir., 2019 U.S. App. LEXIS 9946). (Source: LexisNexis® Mealey's™ Disability Insurance Legal News)
Source: LexisNexis® Mealey's™ Disability Insurance Legal News - May 14, 2019 Category: Medical Law Source Type: news

Managing the Emotional Side of Migraines
How can you help migraine patients who suffer from psychiatric conditions such as depression or anxiety? A headache expert says a simple question can make a huge impact.   (Source: ConsultantLive)
Source: ConsultantLive - May 14, 2019 Category: Internal Medicine Authors: Jordan Rosenfeld Tags: Headache and Migraine Source Type: news

Improve your memory and ease migraine with a ZAP to the brain 
Neuro-electrostimulation is already being used to treat a variety of ailments.We asked leading experts what brain-zapping techniques are making waves in clinics. (Source: the Mail online | Health)
Source: the Mail online | Health - May 14, 2019 Category: Consumer Health News Source Type: news

Iowa-Bred Dogs Have Disease That Can Pass to Humans
While the threat to pet owners is low, human symptoms include fever, sweats, headache, joint pain and weakness, the state health department said. (Source: WebMD Health)
Source: WebMD Health - May 13, 2019 Category: Consumer Health News Source Type: news

OMRON VENTURES Joins Theranica's Series B Funding Round as Strategic Investor
Strategic investment signals positive response of healthcare community to Theranica's new approach to migraine management NETANYA, Israel, May 13, 2019 -- (Healthcare Sales & Marketing Network) -- Theranica today announced OMRON VENTURES has joined its... Devices, Neurology, Venture Capital Theranica Bio-Electronics, Nerivio Migra, neuromodulation, migraine (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - May 13, 2019 Category: Pharmaceuticals Source Type: news

Lilly's new migraine drug pulls ahead of Amgen in fierce battle for new prescriptions
Eli Lilly and Co has pulled ahead in a three-way race with Amgen Inc and Teva Pharmaceutical Industries Ltd in attracting new patients to a new class of migraine drugs, and seeks to build on that advantage by stressing that its therapy can completely prevent headaches in a small percentage of patients. (Source: Reuters: Health)
Source: Reuters: Health - May 11, 2019 Category: Consumer Health News Tags: healthNews Source Type: news

Migraines During Pregnancy Can Increase Risks To Mother, Baby
BOSTON (CBS) – Many women of reproductive age suffer from migraines, but a new study out of Denmark finds that having these painful headaches during pregnancy may put the mother and the baby at risk. Danish researchers studied more than more than 200,000 pregnancies and found that women who had migraines during their pregnancies were at higher risk of pregnancy-related hypertension and preeclampsia and that their babies were at a higher risk of complications like low birth weight, preterm birth, respiratory problems and seizures. The hope is that treatment of migraines during pregnancy may reduce these risks to mothe...
Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire - May 9, 2019 Category: Consumer Health News Authors: Health – CBS Boston Tags: Boston News Health Healthwatch Syndicated Local Dr. Mallika Marshall Migraines Pregnancy Source Type: news

Migraines may increase risk of pregnancy complications
(Wiley) In a study of women in Denmark with and without migraines who became pregnant, migraines were associated with an increased risk of pregnancy-associated hypertension disorders in the mother. Also, in newborns, maternal migraine was associated with an increased risk of a variety of adverse outcomes, including low birth weight, preterm birth, cesarean delivery, respiratory distress syndrome, and febrile seizures. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - May 9, 2019 Category: International Medicine & Public Health Source Type: news

Pregnant women who suffer migraines are 'more likely to have a miscarriage
Researchers from Aarhus University Hospital in Denmark compared the pregnancies of 22,841 women who get migraines with 228,324 women who do not over a seven-year period. (Source: the Mail online | Health)
Source: the Mail online | Health - May 9, 2019 Category: Consumer Health News Source Type: news

Are Sleeping Pills Safe? Here ’s What Research Says
According to the latest numbers, roughly 9 million Americans — 4% of U.S. adults — use prescription sleep aids, or medications that can help with insomnia and other sleep issues. And now, some of the most popular prescription sleep drugs must carry stronger safety warnings. In April, the Food and Drug Administration (FDA) mandated black-box warnings — which the agency uses to “call attention to serious or life-threatening risks” — on three sedative-hypnotic sleep aids: eszopiclone (often sold under the brand name Lunesta), zaleplon (Sonata) and zolpidem (Ambien). Hypnotic drugs, which ar...
Source: TIME: Health - May 7, 2019 Category: Consumer Health News Authors: Jamie Ducharme Tags: Uncategorized Drugs Source Type: news

New Studies in Neurology: April 2019 New Studies in Neurology: April 2019
Dr Christoph Diener discusses new studies in neurology investigating acute ischemic stroke, carotid stenosis, migraine, multiple sclerosis, and cognitive decline.Medscape Neurology (Source: Medscape Neurology and Neurosurgery Headlines)
Source: Medscape Neurology and Neurosurgery Headlines - May 7, 2019 Category: Neurology Tags: Neurology & Neurosurgery Commentary Source Type: news

Headache Triggers as Surprise Headache Triggers as Surprise
The authors present a new model of headache triggers which characterizes them not only by their mechanism of action, but also on the degree of rarity or unexpectedness in relation to past exposures.Headache (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - May 7, 2019 Category: Consumer Health News Tags: Neurology & Neurosurgery Journal Article Source Type: news

NHS funds handheld headache-busting device as part of Long Term Plan
A device that can zap away excruciating headaches is to receive NHS England funding from a scheme that helps to spread the use of world-leading technology across the health service. (Source: NHS Networks)
Source: NHS Networks - May 7, 2019 Category: UK Health Source Type: news

NHS funds headache relieving device
The handheld device delivers low-level electric currents to disrupt cluster headaches Related items fromOnMedica NICE calls for consistent clinical and social care in cerebral palsy Stroke survivors need more help taking medicine Ending the postcode lottery of stroke care BMA calls for ‘national standard for autism care’ Clinicians need better options if we are to stop over-medication (Source: OnMedica Latest News)
Source: OnMedica Latest News - May 7, 2019 Category: UK Health Source Type: news

Confounding, mediation, or independent effect? Childhood psychological abuse, mental health, mood/psychological state, COPD and migraine - Sheikh MA.
In some settings, it may be difficult to differentiate between a confounder and a mediator. For instance, the observed association of self-reported childhood psychological abuse (CPA) with onset of chronic obstructive pulmonary disease (COPD) and migraine ... (Source: SafetyLit)
Source: SafetyLit - May 6, 2019 Category: International Medicine & Public Health Tags: Age: Adolescents Source Type: news

Amgen To Highlight Extensive Long-Term Safety And Efficacy Data Of Aimovig ® (erenumab-aooe) Across The Spectrum Of Migraine At AAN Annual Meeting
After Long-Term Aimovig Treatment, Two-Thirds of Chronic Migraine Patients Converted to Episodic Migraine, Experiencing 11 Fewer Migraine Days per Month on Average Separate Study Showed the Majority of Episodic Migraine Patients on Aimovig Reported at Least a 50 Percent Reduction in Monthly Migraine Days at One Year, With One in Five Being Completely Migraine-Free Aimovig is the Most Prescribed Anti-CGRP Therapy - Approximately 200,000 Patients in the U.S. Have Been Prescribed Aimovig Since Launch[1] THOUSAND OAKS, Calif., May 2, 2019 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced that it will present new lon...
Source: Amgen News Release - May 2, 2019 Category: Pharmaceuticals Tags: Uncategorized Source Type: news

Best supplements for migraines: Plant supplement proven to prevent the severe headache
BEST supplements for migraines: A migraine is a severe headache that causes throbbing pain on one side of the head and often it ’s treated with painkillers. But for those looking for a more natural remedy, a certain plant supplement has proven effective. (Source: Daily Express - Health)
Source: Daily Express - Health - May 2, 2019 Category: Consumer Health News Source Type: news

Scorecard: A year ago CHS was sued by Microsoft. Here's what's happened since.
Scorecard checks back on our headlines from a year ago. This is an update to the April 4, 2018, story "CHS ’ latest headache: A lawsuit from Microsoft." (Source: bizjournals.com Health Care News Headlines)
Source: bizjournals.com Health Care News Headlines - May 2, 2019 Category: Health Management Authors: Joel Stinnett Source Type: news

Scorecard: A year ago CHS was sued by Microsoft. Here's what's happened since.
Scorecard checks back on our headlines from a year ago. This is an update to the April 4, 2018, story "CHS ’ latest headache: A lawsuit from Microsoft." (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - May 2, 2019 Category: Biotechnology Authors: Joel Stinnett Source Type: news

High blood pressure: Does your headache feel like this? When it could be something serious
HIGH blood pressure symptoms include chest pain, finding blood in your urine, and even shortness of breath. But you could also be at risk of deadly hypertension if you often have painful headaches. This is when your headache could be caused by high blood pressure. (Source: Daily Express - Health)
Source: Daily Express - Health - May 1, 2019 Category: Consumer Health News Source Type: news

Medical News Today: What causes dizziness when lying down?
Dizziness while lying down, or benign paroxysmal positional vertigo, has many causes, including head injuries, diabetes, and migraines. Treatment depends on the cause. Learn more here. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - May 1, 2019 Category: Consumer Health News Tags: Ear, Nose and Throat Source Type: news

Digital Health Plays Larger Role in MDEA for 2019
For more than 20 the Medical Design Excellence Awards have celebrated medtech products that improve the quality of healthcare and accessibility. From prosthetic legs to breast pumps, over the years, MDEA has always been a spotlight of the greatest innovation in medtech. This year was no different – with a wide variety of innovations coming from all segments of medtech. Just like any other year, jurors from all over the country shuffled into a conference room at the Anaheim Convention Center to see which products would be finalists for the MDEA. One trend seemed to stand out – the increas...
Source: MDDI - April 30, 2019 Category: Medical Devices Authors: Omar Ford Tags: Design News Source Type: news

Declining sense of smell linked to premature mortality
Study shows even healthy individuals may be at risk although reasons are unclear Related items fromOnMedica Celebrities back brain donation campaign UK C-diff testing "inaccurate and inconsistent" A healthy middle age combats dementia Alzheimer's link to reduced cancer risk Aura migraines double stroke risk in some groups (Source: OnMedica Latest News)
Source: OnMedica Latest News - April 30, 2019 Category: UK Health Source Type: news

Increased suicidality in patients with cluster headache - Ji Lee M, Cho SJ, Wook Park J, Kyung Chu M, Moon HS, Chung PW, Myun Chung J, Sohn JH, Kim BK, Kim BS, Kim SK, Song TJ, Choi YJ, Park KY, Oh K, Ahn JY, Lee KS, Cho S, Chung CS.
OBJECTIVE: To investigate suicidality related to cluster headache and factors associated with increased suicidality in cluster headache patients. METHODS: In this multicenter study, 193 cluster headache patients were recruited between September 201... (Source: SafetyLit)
Source: SafetyLit - April 29, 2019 Category: International Medicine & Public Health Tags: Suicide and Self-Harm Source Type: news

The obscure advisory committees at the heart of the U.S. drug pricing debate
Expectations were high last year for three new migraine drugs hitting the market from Amgen Inc, Eli Lilly and Co and Teva Pharmaceutical Industries. (Source: Reuters: Health)
Source: Reuters: Health - April 29, 2019 Category: Consumer Health News Tags: healthNews Source Type: news

Flunarizine as Prophylaxis for Episodic Migraine Flunarizine as Prophylaxis for Episodic Migraine
Although not approved in the US, the calcium channel blocker flunarizine has been used for 30 years as a prophylactic drug in migraine. This meta-analysis examined its safety and efficacy.Pain (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - April 25, 2019 Category: Consumer Health News Tags: Neurology & Neurosurgery Journal Article Source Type: news

In quest to control migraines, Peninsula company raises $62 million to send drug up your nose
Marrying the old and the new, this South San Francisco company is taking its experimental treatment for acute migraines into a huge late-stage clinical trial. (Source: bizjournals.com Health Care News Headlines)
Source: bizjournals.com Health Care News Headlines - April 24, 2019 Category: Health Management Authors: Ron Leuty Source Type: news

In quest to control migraines, Peninsula company raises $62 million to send drug up your nose
Marrying the old and the new, this South San Francisco company is taking its experimental treatment for acute migraines into a huge late-stage clinical trial. (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - April 24, 2019 Category: Biotechnology Authors: Ron Leuty Source Type: news

Teva Scraps Cluster Headache Program Teva Scraps Cluster Headache Program
Teva Pharmaceutical Industries Ltd said on Tuesday it would stop developing its migraine drug, Ajovy, for treating cluster headaches.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - April 24, 2019 Category: Consumer Health News Tags: Neurology & Neurosurgery News Source Type: news

Satsuma Pharmaceuticals Raises $62 Million in Series B Preferred Stock Financing
Funding supports Phase 3 development of STS101 for the acute treatment of migraine, including pivotal Phase 3 efficacy trial with planned initiation in Q3 2019 SOUTH SAN FRANCISCO, Calif., April 24, 2019 -- (Healthcare Sales & Marketing Network) -- Sat... Biopharmaceuticals, Drug Delivery, Venture Capital Satsuma Pharmaceuticals, dihydroergotamine, nasal powder, migraine (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - April 24, 2019 Category: Pharmaceuticals Source Type: news

Teva halts tests of its migraine drug as a cluster headache remedy
After the treatment was found unlikely to meet its goal in a late-stage trial, the drugmaker's migraine drug Ajovy will stop being developed in this manner (Source: PharmaManufacturing.com)
Source: PharmaManufacturing.com - April 23, 2019 Category: Pharmaceuticals Source Type: news

Teva stops testing its migraine drug as cluster headache treatment
Teva Pharmaceutical Industries Ltd said on Tuesday it would stop developing its migraine drug, Ajovy, for treating cluster headaches after the company found the treatment was unlikely to meet the main goal of a late-stage trial. (Source: Reuters: Health)
Source: Reuters: Health - April 23, 2019 Category: Consumer Health News Tags: healthNews Source Type: news

Almost 20 Percent Of Multiple Sclerosis Diagnoses Are False, Study Finds
BOSTON (CBS) — Some sobering news for people diagnosed with multiple sclerosis: researchers at Cedars Sinai, UCLA, and the University of Vermont found that nearly one-in-five people diagnosed with MS do not actually have it. Diagnosing MS can be challenging because the symptoms and even the finding on MRI can mimic other conditions. After studying 241 cases, researchers found that almost 18 percent of people referred to two Los Angeles MS centers didn’t actually meet the criteria for MS and in fact, had something else…most commonly migraine but also spine problems or nerve damage. Wrongly diagnosed patie...
Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire - April 22, 2019 Category: Consumer Health News Authors: Health – CBS Boston Tags: Boston News Health Healthwatch Seen On WBZ-TV Syndicated Local Uncategorized Dr. Mallika Marshall Misdiagnosis Multiple Sclerosis Source Type: news

Monarch Becomes the 1st FDA-Cleared Device for ADHD
The Monarch external Trigeminal Nerve Stimulation (eTNS) System made history last week after it became the first device to win a nod from FDA to treat attention deficit hyperactivity disorder (ADHD). It should be noted the technology has had CE mark since 2015. Monarch was developed by NeuroSigma and is indicated to help treat 7 to 12-year-olds suffering from ADHD. What makes this de novo clearance from FDA so significant is that typically pharmaceutical solutions are used to treat patients suffering from the neurological disorder. Monarch is about the size of a cellphone. The device generates a low-level electrical pulse ...
Source: MDDI - April 22, 2019 Category: Medical Devices Authors: Omar Ford Tags: Digital Health Source Type: news

A review of the role of auditory evoked potentials in mild traumatic brain injury assessment - Washnik NJ, Anjum J, Lundgren K, Phillips S.
Around 75% to 90% of people who experience a traumatic brain injury (TBI) are classified as having a mild TBI (mTBI). The term mTBI is synonymous with concussion or mild head injury (MHI) and is characterized by symptoms of headache, nausea, dizziness, and... (Source: SafetyLit)
Source: SafetyLit - April 22, 2019 Category: International Medicine & Public Health Tags: Ergonomics, Human Factors, Anthropometrics, Physiology Source Type: news

FDA Approves First Medical Device To Treat ADHD In Children
(CNN) — The first medical device to treat childhood attention deficit hyperactivity disorder, or ADHD, was OK’d Friday by the US Food and Drug Administration. Designated for children ages 7 to 12 who are not currently on medication for the disorder, the device delivers a low-level electrical pulse to the parts of the brain responsible for ADHD symptoms. “This new device offers a safe, non-drug option for treatment of ADHD in pediatric patients through the use of mild nerve stimulation, a first of its kind,” Carlos Peña, director of the Division of Neurological and Physical Medicine Devices in...
Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire - April 22, 2019 Category: Consumer Health News Authors: Health – CBS Boston Tags: Health News CNN ADHD Source Type: news

What Are Some Potential Indicators of Human Trafficking?
Discussion Human trafficking is estimated to be the second largest criminal activity in the world after illegal arms trafficking. It affects all nations with an estimated 27 million people of all ages worldwide but only a small number are identified. It is defined by the United Nations as “the recruitment, transfer, harboring, or receipt of persons by means of threat or use of force or other forms of coercions, abduction, fraud, deception, the abuse of power, or a position of vulnerability to achieve the consent of a person, having control over another person, for the purpose of exploitation.” It includes comme...
Source: PediatricEducation.org - April 22, 2019 Category: Pediatrics Authors: pediatriceducationmin Tags: Uncategorized Source Type: news

Use lavender essential oil to reduce the frequency and severity of migraines
(Natural News) People suffering from migraines could benefit a lot from lavender, a study published in the Journal of Herbal Medicine suggests. The study, a multi-university effort from Iranian researchers, looked at the effects of lavender essential oil when used in migraine prophylactics. In the three-month study, the researchers enrolled migraine sufferers in a randomized controlled clinical... (Source: NaturalNews.com)
Source: NaturalNews.com - April 18, 2019 Category: Consumer Health News Source Type: news

Decreased grey matter volume in mTBI patients with post-traumatic headache compared to headache-free mTBI patients and healthy controls: a longitudinal MRI study - Burrowes SAB, Rhodes CS, Meeker TJ, Greenspan JD, Gullapalli RP, Seminowicz DA.
In this study we aimed to identify... (Source: SafetyLit)
Source: SafetyLit - April 17, 2019 Category: International Medicine & Public Health Tags: TBI Source Type: news

Headache Treatment Protocols: One Size Does Not Fit All Headache Treatment Protocols: One Size Does Not Fit All
Dr Robert Cowan discusses the reasons why treatment plans for migraine headache should be tailored to each patient.American Headache Society and Medscape (Source: Medscape Neurology and Neurosurgery Headlines)
Source: Medscape Neurology and Neurosurgery Headlines - April 17, 2019 Category: Neurology Tags: Neurology & Neurosurgery Article Source Type: news